Key Points – Aveanna Healthcare posted strong Q1 results, with revenue up 15.9% to about $648 million and adjusted EBITDA up 25.2% to $84.4 million, then raised its full-year 2026 guidance for both revenue and EBITDA. – Growth was broad-based across all three segments: Private…
ty Services, Home Health and Hospice, and Medical Solutions all delivered higher revenue, supported by better reimbursement, volume growth, and operating efficiencies. – Management said the newly announced CMS Medicare enrollment moratorium should not affect Aveanna’s 2026 outlook or growth plans, while the company continues to expand preferred payer agreements and pursue the pending Family First Homecare acquisition. Aveanna Healthcare (NASDAQ:AVAH) raised its full-year 2026 outlook after reporting double-digit revenue and adjusted EBITDA growth in the first quarter, citing improved reimbursement rates, higher volumes and operating efficiencies across its three business segments
Chief Executive Officer Jeff Shaner said revenue for the quarter was approximately $648 million, up 15.9% from the prior-year period, while adjusted EBITDA rose 25.2% to $84.4 million. Shaner said the results reflected progress in aligning caregiver capacity with government and managed care payers willing to support enhanced reimbursement and value-based arrangements. “Our industry does not have a demand problem,” Shaner said, adding that demand for home and community-based care remains strong as state and federal governments and managed care organizations seek ways to expand capacity while reducing total cost of care. Company Raises 2026 Guidance Based on the first-quarter performance and continued execution of its strategic initiatives, Aveanna increased its full-year 2026 revenue guidance to a range of $2.56 billion to $2.58 billion.
The company also raised its adjusted EBITDA guidance to a range of $328 million to $332 million. Shaner said the outlook does not include any contribution from the pending…